Xperi Valuation

Is XPER undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of XPER when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate XPER's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate XPER's fair value for valuation analysis.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for XPER?

Key metric: As XPER is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for XPER. This is calculated by dividing XPER's market cap by their current revenue.
What is XPER's PS Ratio?
PS Ratio0.8x
SalesUS$508.56m
Market CapUS$390.02m

Price to Sales Ratio vs Peers

How does XPER's PS Ratio compare to its peers?

The above table shows the PS ratio for XPER vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average3.7x
AIP Arteris
6.1x15.7%US$339.5m
OSPN OneSpan
2.8x3.8%US$671.3m
SVCO Silvaco Group
4.1x17.5%US$214.6m
TLS Telos
1.9x24.5%US$240.3m
XPER Xperi
0.8x1.8%US$390.0m

Price-To-Sales vs Peers: XPER is good value based on its Price-To-Sales Ratio (0.8x) compared to the peer average (3.7x).


Price to Sales Ratio vs Industry

How does XPER's PS Ratio compare vs other companies in the US Software Industry?

81 CompaniesPrice / SalesEstimated GrowthMarket Cap
Industry Avg.5.3x12.4%
XPER Xperi
0.8x1.8%US$390.02m
VYX NCR Voyix
0.6x-23.2%US$2.13b
PGY Pagaya Technologies
0.7x15.8%US$704.88m
XPER 0.8xIndustry Avg. 5.3xNo. of Companies81PS048121620+
81 CompaniesEstimated GrowthMarket Cap
Industry Avg.5.3x17.2%
XPER Xperi
0.8x19.0%US$390.02m
No more companies

Price-To-Sales vs Industry: XPER is good value based on its Price-To-Sales Ratio (0.8x) compared to the US Software industry average (5.3x).


Price to Sales Ratio vs Fair Ratio

What is XPER's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

XPER PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.8x
Fair PS Ratio1.8x

Price-To-Sales vs Fair Ratio: XPER is good value based on its Price-To-Sales Ratio (0.8x) compared to the estimated Fair Price-To-Sales Ratio (1.8x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst XPER forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$8.71
US$18.75
+115.3%
36.4%US$30.00US$12.00n/a4
Nov ’25US$9.26
US$18.75
+102.5%
36.4%US$30.00US$12.00n/a4
Oct ’25US$9.02
US$18.75
+107.9%
36.4%US$30.00US$12.00n/a4
Sep ’25US$8.82
US$18.75
+112.6%
36.4%US$30.00US$12.00n/a4
Aug ’25US$7.91
US$19.50
+146.5%
31.7%US$30.00US$15.00n/a4
Jul ’25US$7.96
US$19.50
+145.0%
31.7%US$30.00US$15.00n/a4
Jun ’25US$8.81
US$19.50
+121.3%
31.7%US$30.00US$15.00n/a4
May ’25US$10.48
US$19.50
+86.1%
31.7%US$30.00US$15.00n/a4
Apr ’25US$11.66
US$19.50
+67.2%
31.7%US$30.00US$15.00n/a4
Mar ’25US$11.28
US$19.50
+72.9%
31.7%US$30.00US$15.00n/a4
Feb ’25US$10.73
US$18.25
+70.1%
37.4%US$30.00US$13.00n/a4
Jan ’25US$11.02
US$18.25
+65.6%
37.4%US$30.00US$13.00n/a4
Dec ’24US$10.11
US$18.20
+80.0%
33.6%US$30.00US$13.00n/a5
Nov ’24US$8.23
US$18.20
+121.1%
33.6%US$30.00US$13.00US$9.265
Oct ’24US$9.86
US$18.20
+84.6%
33.6%US$30.00US$13.00US$9.025
Sep ’24US$11.74
US$18.20
+55.0%
33.6%US$30.00US$13.00US$8.825
Aug ’24US$13.54
US$18.20
+34.4%
33.6%US$30.00US$13.00US$7.915
Jul ’24US$13.15
US$18.20
+38.4%
33.6%US$30.00US$13.00US$7.965
Jun ’24US$10.57
US$19.00
+79.8%
34.7%US$30.00US$13.00US$8.814
May ’24US$9.58
US$19.25
+100.9%
34.1%US$30.00US$13.00US$10.484
Apr ’24US$10.93
US$19.25
+76.1%
34.1%US$30.00US$13.00US$11.664
Mar ’24US$11.81
US$18.75
+58.8%
37.0%US$30.00US$13.00US$11.284
Feb ’24US$10.41
US$22.00
+111.3%
31.7%US$30.00US$13.00US$10.733
Jan ’24US$8.61
US$22.00
+155.5%
31.7%US$30.00US$13.00US$11.023
Dec ’23US$10.68
US$22.00
+106.0%
31.7%US$30.00US$13.00US$10.113

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.


Discover undervalued companies